Transfer factor — development and research of new pharmaceutical form (Q11224): Difference between revisions
Jump to navigation
Jump to search
(Created claim: summary (P836): The proposed project addresses the preparation of a new pharmaceutical form of specific immunomodulators based on transfer of factors (TF) and methods of testing their immunobiortic potential., Adding English summary) |
(Changed an Item) |
||
| Property / programme | |||
| Property / programme: Enterprise and Innovation for Competitiveness - CZ - ERDF / rank | |||
Normal rank | |||
Revision as of 17:45, 25 March 2020
Project in Czech Republic financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Transfer factor — development and research of new pharmaceutical form |
Project in Czech Republic financed by DG Regio |
Statements
24,083,996.56 Czech koruna
0 references
43,285,400.0 Czech koruna
0 references
55.64 percent
0 references
16 April 2018
0 references
30 April 2020
0 references
AUMED, a.s.
0 references
49°59'56.22"N, 14°25'3.50"E
0 references
14300
0 references
Předložený projekt řeší problematiku přípravy nové lékové formy specifických imunomodulátorů na bázi transfer faktorů (TF) a metod testování jejich imunobiologického potenciálu a. (Czech)
0 references
The proposed project addresses the preparation of a new pharmaceutical form of specific immunomodulators based on transfer of factors (TF) and methods of testing their immunobiortic potential. (English)
0 references
Identifiers
CZ.01.1.02/0.0/0.0/16_083/0010301
0 references